Cargando…
Glucagon and heart in type 2 diabetes: new perspectives
Increased levels of glucagon in type 2 diabetes are well known and, until now, have been considered deleterious. However, glucagon has an important role in the maintenance of both heart and kidney function. Moreover, in the past, glucagon has been therapeutically used for heart failure treatment. Th...
Autores principales: | Ceriello, Antonio, Genovese, Stefano, Mannucci, Edoardo, Gronda, Edoardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002329/ https://www.ncbi.nlm.nih.gov/pubmed/27568179 http://dx.doi.org/10.1186/s12933-016-0440-3 |
Ejemplares similares
-
A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes
por: Genovese, Stefano, et al.
Publicado: (2017) -
Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
por: Uccellatore, Annachiara, et al.
Publicado: (2015) -
ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes
por: Gronda, Edoardo, et al.
Publicado: (2021) -
Insulin Therapy and Cancer in Type 2 Diabetes
por: Mannucci, Edoardo
Publicado: (2012) -
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey
por: Gallo, Marco, et al.
Publicado: (2015)